5th Medical Device Software Development Summit 2025

The global digital health market is set to reach a staggering $660 billion in 2025, growing at a compound annual growth rate of 15.1% from 2020. As demand for cutting-edge medical devices like AI-powered diagnostics, connected diagnostic imaging systems, and remote patient monitoring devices accelerates, manufacturers must navigate a rapidly evolving landscape. With the FDA's AI guidelines and changing cybersecurity standards, ensuring compliance while balancing speed to market and robust security measures has never been more urgent.

Dedicated to navigating the complexities of US and global regulations, addressing cybersecurity vulnerabilities, and managing legacy device updates, the 5th Medical Device Software Development Summit unites industry leaders - from medical device giants to innovative start-ups - to explore actionable strategies, share best practices, and collaborate on solutions for ensuring the continuous compliance and security of cutting-edge software in a rapidly evolving market.


URLs:
Website: https://go.evvnt.com/2891673-0?pid=10018
Tickets: https://go.evvnt.com/2891673-1?pid=10018
Brochure; https://go.evvnt.com/2891673-3?pid=10018

Venue Details: The Royal Sonesta Boston, 40 Edwin H Land Blvd, Boston, Massachusetts, 02142, United States

Prices:
Conference + Workshop Day - Industry - OTD: USD 4197.00,
Conference + Workshop Day - Discounted - OTD: USD 3497.00,
Conference + Workshop Day - Vendor - OTD: USD 5097.00,
Conference Only - Industry - OTD: USD 2999.00,
Conference Only - Discounted - OTD: USD 2599.00,
Conference Only - Vendor - OTD: USD 3699.00,
Workshop Day Only - Industry - OTD: USD 2247.00,
Workshop Day Only - Discounted - OTD: USD 1947.00,
Workshop Day Only - Vendor - OTD: USD 2247.00

Speakers: Adam Heroux, Vice President of Quality and Regulatory Affairs, Kheiron Medical, Andrew O'Keeffe, Executive Director, Global Digital Quality, Olympus, Andrew Wichmann, Senior IP and Licensing Manager, Digital Technology, John Hopkins, Attrayee Chakraborty, Quality Systems Engineer, Analog Devices, Brian Schick Director, Digital Product Strategy and Development Lead, Takeda, Dinendra Ramachandran, Vice President Digital Health Solutions, Convatec, Don Bigler, Vice President, Engineering, IMVARIA, Eleanora Chakraborty, Associate Director, Regulatory Affairs, Strategic Global Labeling, Combination Products and Devices, Abbvie, Ephrat Most, Director, Software Quality Program, Medtronic, James Asimah, Director and Head of Cyber Security and Government, Risk and Compliance, Highridge Medical, Jason Domask, Director, Software Engineering, Heart Sciences, Jason Gorman, Director, Global Product Regulatory Affairs, ResMed, Joshua Guo, Associate Director, Emerging Technologies Regulatory and Quality Lead, Biogen, Joshua Kupke Director, Research and Product Development, Enovis, Joshua Park, Chief Executive Officer, Global Biomedical, Manil Asija, Principal Engineer Quality Engineering, Analog Devices, Michael Iglesias, Associate Director, Quality Assurance, Merck, Neeraj Mainkar, Vice President, Software Engineering, Vicarious Surgical, Phani Bidarahalli, Senior Director, Surgical Innovations, Research and Development, Medtronic, Richard Jackson, Director of Software, FluxErgy, Sam Rajkumar, Director, Regulatory Affairs, Quality Assurance and Security Digital Healthcare, Analog Devices, Sarah Rickert, Director of Quality and Regulatory Affairs, Werfen, Seth Kuzdzal, Senior Vice President, Quality Assurance and Regulatory Affairs, Biofourmis, Srutiparna Lahkar, Senior Quality Lead, Genentech, Stephen Odaibo, Founder, Chief Executive Officer and Software Architect, RETINA-AI Health, Sucheth Koppa, Head of Software Computational Science Informatics Verification Validation, Research and Development, Roche, Tara Larson, Product Security Director, Chief Security Architect, Abbott Laboratories, Timothy Ruchti, Director, Algorithms, Nihon Kohden Corporation, Tura Oullette, Director of Regulatory Affairs, Straumann Group